The following is a reconciliation of the Company’s basic weighted average common shares outstanding to diluted weighted average common shares outstanding during the periods presented (in thousands): | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | | | 2025 | | 2026 | | 2025 | | 2026 | | Basic weighted average number of common shares outstanding | | 310,323 | | 309,712 | | 310,822 | | 309,325 | | Add: Dilutive effect of RSUs | | 911 | | 326 | | 1,305 | | 678 | | Add: Dilutive effect of PSUs | | 1,950 | | 605 | | 1,969 | | 928 | | Diluted weighted average number of common shares outstanding | | 313,184 | | 310,643 | | 314,096 | | 310,931 | | | | | | | | | | | | Weighted average number of outstanding securities excluded from calculation of diluted net income per common share (1): | | | | | | | | | | RSUs | | — | | 8 | | — | | 4 | | Stock options | | 42 | | — | | 146 | | — | |
| (1) | The potential dilutive effects of these securities were excluded from the computation of net income per common share—diluted because the inclusion of these securities would have been anti-dilutive. |
|